Latest news

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions.

Bormioli Pharma has always been a promoter of innovation, which translates not only into the development and adoption of advanced technological solutions, but also into a consulting approach aimed at transforming the future of the pharmaceutical industry and the world of healthcare.

The packaging of ophthalmic medicines plays a crucial role in the safety and efficacy of eye treatments. From sterility solutions to sustainable materials and new preservative-free dosing systems, innovations aim to improve the patient experience and reduce environmental impact. Discover the latest challenges and trends in the industry, where technology and sustainability merge to ensure safer and more accessible eye care.

Bormioli Pharma today announced a partnership with Chiesi, an international, research-focused biopharmaceutical company (Chiesi Group), to supply Carbon Capture PET bottles. These will be used to package a medication indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis.

From 8th to 10th October in Milan (Fiera Milano, booth 20A2), the company will showcase EcoPositive, one of the widest pharma-grade low impact product ranges available on the market, featuring over 3,000 items.

Asamedic, a pioneer in emergency medical treatment of myocardial infarction, and Bormioli Pharma announce their partnership for the commercialization of Coxor™ 300mg Acetylsalicylic acid, revolutionary life-saving medication designed for emergency treatment of suspected acute myocardial infarction.